Wendell A. Lim

Active 1988–2024

120
Papers
43,355
Citations
98
h-index
119
i10-index

Citations

Citations per year for Wendell A. Lim1974: 1 citations1982: 1 citations1987: 1 citations1988: 2 citations1989: 5 citations1990: 30 citations1991: 38 citations1992: 33 citations1993: 42 citations1994: 43 citations1995: 88 citations1996: 51 citations1997: 63 citations1998: 39 citations1999: 78 citations2000: 110 citations2001: 151 citations2002: 138 citations2003: 190 citations2004: 177 citations2005: 188 citations2006: 168 citations2007: 189 citations2008: 207 citations2009: 253 citations2010: 328 citations2011: 261 citations2012: 386 citations2013: 414 citations2014: 554 citations2015: 534 citations2016: 664 citations2017: 778 citations2018: 770 citations2019: 1,768 citations2020: 1,827 citations2021: 1,726 citations2022: 1,435 citations2023: 1,073 citations2024: 1,704 citations2025: 889 citations2026: 32 citations1975–1981: no citations, so these years are not shown1983–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,257 citing papers, 36.2% of this breakdownChina: 2,149 citing papers, 12.4% of this breakdownGermany: 1,068 citing papers, 6.2% of this breakdownUnited Kingdom: 1,047 citing papers, 6% of this breakdownCanada: 558 citing papers, 3.2% of this breakdownFrance: 514 citing papers, 3% of this breakdownJapan: 485 citing papers, 2.8% of this breakdownSwitzerland: 409 citing papers, 2.4% of this breakdownIndia: 364 citing papers, 2.1% of this breakdownSpain: 326 citing papers, 1.9% of this breakdownItaly: 322 citing papers, 1.9% of this breakdownSouth Korea: 322 citing papers, 1.8% of this breakdown
0%36.2%Other 20.1%

Fields

  • Biochemistry, Genetics and Molecular Biology64%
  • Medicine18.9%
  • Neuroscience4.4%
  • Immunology and Microbiology3.3%
  • Agricultural and Biological Sciences2.4%
  • Engineering2.1%
  • Other4.9%

Topics

  • CRISPR and Genetic Engineering9.1%
  • CAR-T cell therapy research4.4%
  • RNA and protein synthesis mechanisms3.6%
  • Gene Regulatory Network Analysis2.6%
  • Advanced biosensing and bioanalysis techniques2.1%
  • Protein Structure and Dynamics2%
  • Other76.2%

Coauthors

All papers

Open in search
  1. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

    Authors: , , , , , , - Cell 2013 cited by 5,248

  2. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

    Authors: , , , , , , , , , , , , - Cell 2013 cited by 3,860

  3. Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors

    Authors: , , , , , , - Cell 2016 cited by 1,068

  4. SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 495

  5. CRISPR interference (CRISPRi) for sequence-specific control of gene expression

    Authors: , , , , , - Nature Protocols 2013 cited by 1,258

  6. The Principles of Engineering Immune Cells to Treat Cancer

    Authors: , - Cell 2017 cited by 1,105

  7. Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits

    Authors: , , , , , , - Cell 2016 cited by 1,034

  8. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors

    Authors: , , , , , , , , - Cell 2016 cited by 749

  9. CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

    Authors: , , , , , , - Scientific Reports 2017 cited by 744

  10. Synthetic cytokine circuits that drive T cells into immune-excluded tumors

    Authors: , , , , , , , , , , , , , , , - Science 2022 cited by 226

  11. Remote control of therapeutic T cells through a small molecule–gated chimeric receptor

    Authors: , , , , - Science 2015 cited by 698

  12. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds

    Authors: , , , , , , , , , , - Cell 2014 cited by 956

  13. Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning

    Authors: , , , , , , , , - Science 2022 cited by 127

  14. Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation

    Authors: , , - Nature Reviews Molecular Cell Biology 2015 cited by 837

  15. Programming self-organizing multicellular structures with synthetic cell-cell signaling

    Authors: , , , , - Science 2018 cited by 492

  16. Spatiotemporal control of cell signalling using a light-switchable protein interaction

    Authors: , , , - Nature 2009 cited by 1,038

  17. Programming multicellular assembly with synthetic cell adhesion molecules

    Authors: , , , , , , , , , , - Nature 2022 cited by 165

  18. Defining Network Topologies that Can Achieve Biochemical Adaptation

    Authors: , , , , - Cell 2009 cited by 985

  19. CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity

    Authors: , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2023 cited by 66

  20. Complex transcriptional modulation with orthogonal and inducible dCas9 regulators

    Authors: , , , , , - Nature Methods 2016 cited by 348

  21. DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation

    Authors: , , , , , , , , , , , , - Nature Nanotechnology 2020 cited by 114

  22. Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information

    Authors: , , - Science 2011 cited by 907

  23. The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , W. Todd Miller, William McGinnis, Harris Shapiro, Robert Tjian, Igor V. Grigoriev, Daniel S. Rokhsar - Nature 2008 cited by 1,172

  24. Systematic Functional Prioritization of Protein Posttranslational Modifications

    Authors: , , , , , , , , , - Cell 2012 cited by 457